The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes-Reference-Cited by-同舟云学术

The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes

Published:2020-09-09 Issue:10 Volume:60 Page:2192-2198
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Cheok Kathleen P. L.¹,Chhetri Rakchha¹²³,Wee Li Yan A.¹²,Friel Oisin¹,Pham Anh⁴,Salvi Arabelle⁵,McRae Simon¹,Bardy Peter¹,Singhal Deepak¹²⁶,Roxby David J.⁷,Wood Erica M.⁸⁹,Hiwase Devendra K.¹²⁶^ORCID

Affiliation:

1. Department of Haematology Royal Adelaide Hospital Adelaide South Australia Australia

2. Precision Medicine Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia

3. School of Public Health University of Adelaide Adelaide South Australia Australia

4. Department of Haematology Blood Bank,Royal Adelaide Hospital Adelaide South Australia Australia

5. SA Pharmacy Royal Adelaide Hospital Adelaide South Australia Australia

6. School of Medicine University of Adelaide Adelaide South Australia Australia

7. College of Medicine and Public Health Flinders University Bedford Park South Australia Australia

8. Transfusion Research Unit Monash University Melbourne Victoria Australia

9. Monash Health Melbourne Victoria Australia

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16029

Reference21 articles.

1. The incidence and impact of thrombocytopenia in myelodysplastic syndromes

2. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

3. Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

4. Guidelines for the use of platelet transfusions

5. Relative Importance of Immune and Non-Immune Causes of Platelet Refractoriness

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet transfusion;Current Opinion in Hematology;2024-09-06

2. Transfusion Support of Patients with Myelodysplastic Syndromes;Clinics in Laboratory Medicine;2023-12

3. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes;European Journal of Haematology;2023-07-15

4. Supportive Care for Patients With Myelodysplastic Syndromes;The Cancer Journal;2023-05

5. Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim;Transfusion and Apheresis Science;2023-04